[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 filing notifies a proposed sale of 1,112,004 shares of common stock through Goldman Sachs & Co. LLC with an aggregate market value of $103,794,453.36, and lists 370,470,348 shares outstanding. The filing states the shares were acquired as founder shares from the issuer on 02/25/2019 and that payment was None at acquisition. It also discloses multiple recent sales by related trusts on 08/14/2025 and 08/15/2025, including a sale of 2,556,000 shares for $231,445,800. The filer represents they are not aware of any undisclosed material adverse information.

Positive

• Sale routed through a major broker (Goldman Sachs & Co. LLC), indicating use of standard institutional execution channels
• Acquisition history disclosed: shares identified as founder shares acquired on 02/25/2019, supporting transparency about origin of holdings
• Prior related sales disclosed with transaction dates and proceeds, enhancing transparency about recent insider/affiliate liquidity

Negative

• Large insider/affiliate sales in August 2025 (including 2,556,000 shares for $231,445,800) could increase public float and near-term share supply
• Proposed sale size disclosed (1,112,004 shares) is sizable relative to total outstanding shares and may be viewed as material by some investors

Insights

Securities Analyst

TL;DR: Founder-origin shares and large recent trust disposals signal ongoing insider liquidity actions; monitor share supply implications.

The filing documents a proposed sale of 1,112,004 founder shares via a major broker at an indicated aggregate market value of $103.8 million. Prior disposals by affiliated trusts on August 14-15, 2025, show substantial realized proceeds, notably 2,556,000 shares for $231.4 million. These disclosures are routine for Rule 144 compliance but are material insofar as they increase public float and reveal insider monetization timing. No earnings or operational data are provided in this form; the impact is primarily on share supply and near-term liquidity.

Corporate Governance Expert

TL;DR: The filing meets Rule 144 disclosure expectations; representation on material nonpublic information is key for compliance.

The notice shows the seller acquired the securities as founder shares in 2019 and is relying on Rule 144 sale procedures, using an established broker. The signer affirms no undisclosed material adverse information exists. Recent large trust sales are disclosed, which is important for transparency around insider and affiliate liquidity. From a governance perspective, the filing is standard and provides the necessary investor-facing transparency about insider dispositions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	1112004	103794453.36	370470348	09/02/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/25/2019	Founder Shares	The Issuer			1112004	02/25/2019	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Coconut Tree Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	120000	10866000
Apple Tree Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	120000	10866000
CW Holding 987 LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	2556000	231445800
Birch Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
Willow Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
Maple Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
Chestnut Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
CW Holding 987 LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/15/2025	1000000	100201200

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold under the Form 144 for CoreWeave (CRWV)?

The filing proposes the sale of 1,112,004 shares of CoreWeave common stock through Goldman Sachs & Co. LLC.

What is the aggregate market value of the shares proposed for sale?

The aggregate market value is reported as $103,794,453.36.

When were the shares to be sold originally acquired?

The shares were acquired as founder shares from the issuer on 02/25/2019.

Have there been recent related-party sales disclosed?

Yes. Multiple trusts sold shares on 08/14/2025 and 08/15/2025, including a sale of 2,556,000 shares for $231,445,800.

Does the filer assert possession of any undisclosed material information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Which exchange is named for the planned sale?

The filing lists the exchange as NASD for the proposed sale date of 09/02/2025.